Table. Overview of longitudinal samples used in study of SARS-CoV-2 seroprevalence and immunity in cats, United Kingdom, April 2020–February 2022*.
Sample | Days between sampling | Titer |
% Decrease per day |
|||||
---|---|---|---|---|---|---|---|---|
B.1 | Alpha | Delta | B.1 | Alpha | Delta | |||
Cat F | 12 | 490 | 257 | 601 | 5.90 | 0.90 | 4.10 | |
|
|
146 |
229 |
303 |
|
|
|
|
Cat G | 175 | 586 | 677 | 243 | 0.40 | 0.40 | 0.40 | |
|
|
134 |
170 |
58 |
|
|
|
|
Cat H | 94 | 687 | 825 | 2,165 | 0.30 | 0.20 | 0.70 | |
|
|
474 |
678 |
685 |
|
|
|
|
Cat J | 175 | 627 | 719 | 247 | 0.30 | 0.40 | 0.40 | |
|
|
318 |
241 |
79 |
|
|
|
|
Cat L | 23 | 109 | 102 | 468 | −7.20 | 1.40 | 1.60 | |
289 | 70 | 301 |
*We used 2 samples from each of 5 animals, taken >12 d apart. The earlier sample was used in the overall analysis; however, newer samples were also tested. Values related to each variant are shown for each sample, with the earlier sample above and later below. Titers are color-coded by size (stronger titers and greater decreases are shown with darker shading). B.1 indicates ancestral/wild-type virus.